Compliance and Complications in Catecholaminergic Polymorphic Ventricular Tachycardia

Authors

Shankar Baskar, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH. Electronic address: Shankar.Baskar@CCHMC.org.
Charles I. Berul, Children's National Hospital, George Washington University School of Medicine, Washington, DC.

Document Type

Editorial

Publication Date

4-22-2024

Journal

Heart rhythm

DOI

10.1016/j.hrthm.2024.04.073

Abstract

Based on this robust study, one can conclude that symptomatic pediatric CPVT patients are at high risk for arrhythmic syncope, SCA and SCD even when receiving medical treatment. Compliance and underdosing with medications play a major role in these risks. LCSD may be underutilized in CPVT. ICDs are protective against these risks but at the cost of a high rate of appropriate and inappropriate shocks and other complications.

APA Citation

Baskar, Shankar and Berul, Charles I., "Compliance and Complications in Catecholaminergic Polymorphic Ventricular Tachycardia" (2024). GW Authored Works. Paper 4692.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/4692

Department

Pediatrics